CompoAtlas

Phytotum Vinaigre Détox Foie

Food supplement declared in France

Phytotum Vinaigre Détox Foie, from HELENE FLECHET, is a food supplement declared in France. Status: withdrawn from the market (date not given in Compl'Alim). Main ingredients: Rosmarinus officinalis 2.3 g per day, Cichorium intybus 2 g per day, Vinaigre de cidre. None of the rules we check flags an issue with its declared composition.

Brand
Phytotum
Food business operator placing the product on the market
HELENE FLECHET
Status
Withdrawn from the market (date not given in Compl'Alim)
Form
Autre : vinaigre de plantes
Daily dose
30 ml
Directions for use
2 cuillères à soupe par jour aux repas
Intended populations
Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Liver problems, Prolonged use
Objectives stated by the manufacturer (these are not authorised claims)
Detox / Drainage

Declaration 6683, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Rosmarinus officinalis L.FeuilleAutre macérât2.3 g
Cichorium intybus L.FeuilleAutre macérât2 g

Other active ingredients

NamePer day
Vinaigre de cidrenot declared

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne remplace pas un traitement médical approprié Ne se substitue pas à une alimentation et un mode de vie sains Tenir hors de portée des jeunes enfants Ne pas dépasser la dose conseillée (30ml) Déconseillé aux enfants de moins de 12 ans et aux femmes enceintes ou allaitantes Déconseillé en cas d'allergie croisée connue, en particulier aux plantes de la famille des Astéracées Déconseillé en cas d’obstruction biliaire ou d’autres troubles de la fonction biliaire Déconseillé en cas d'épilepsie Ne pas utiliser de façon prolongée : cure d'1 semaine Agiter avant emploi Conserver dans un endroit frais et à l’abri de la lumière.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Rosmarinus officinalis L.
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    Sources cited by Health Canada (1)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Phytotum

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Phytotum Vinaigre Détox Foie: composition and regulation”, https://compoatlas.com/en/supplements/products/6683-phytotum-vinaigre-detox-foie, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line